SCHEMBL2198749

SCHEMBL2198749

COC(=O)c1ccc(C)c(C(=O)c2ccc(Nc3cccc(F)c3C)cc2Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 13/20 0.54
MAPK13 O15264 12/20 0.54
MAPK12 P53778 12/20 0.54
MAPK11 Q15759 12/20 0.54
TP53 P04637 1/20 0.42
MAPT P10636 4/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CASP3 P42574 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
BCL6 P41182 1/20 0.40
BCOR Q6W2J9 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KDM4E B2RXH2 1/20 0.40
NFKB1 P19838 1/20 0.40
HTT P42858 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2198124 0.90 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2196661 0.90 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11AVPR2
SCHEMBL2199858 0.85 MAPK14 (0.52) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2199428 0.85 MAPK14 (0.60) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2199501 0.85 MAPK13 (0.55) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL1907229 0.84 MAPK14 (0.76) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2196285 0.84 MAPK14 (0.49) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL2199405 0.84 MAPK14 (0.61) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2199523 0.84 MAPK14 (0.72) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL2198871 0.83 MAPK14 (0.48) MAPK14MAPK13MAPK12MAPK11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK14 697/4885MAPK13 1063/4885MAPK12 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.